Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13).
Neuropsychiatr Dis Treat
; 13: 973-980, 2017.
Article
em En
| MEDLINE
| ID: mdl-28408831
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article